Anesthesia device is a medical tool that is used by surgeon to induce and maintain anesthesia during a patient’s surgery. The device is mainly used to mix anesthetic gases and vapors. During surgery, anesthesia devices are used to control pain, breathing, blood pressure, blood flow, and heart rate and rhythm. Anesthesia devices includes monitors, continuous-flow anesthetic machine, anesthetics vaporizers, anesthesia information management system (AIMS), ventilators, catheters, breathing systems, airways. Anesthesia devices are divided into respiratory devices and vascular access devices.
Market Dynamics
Anesthesia devices are used commonly in all types of surgeries as they are designed to offer an accurate and continuous supply of mixed medical gases with aesthetic vapors, which are delivered to patient at a safe pressure and flow. Increasing number of patients suffering from respiratory diseases is expected to boost growth of the market. According to the reports published by the World Health Organization, on May 20, 2022, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Whereas 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC) such as India and Bangladesh.
Furthermore, according to the same source, on May 11, 2022, Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths globally. Most asthma-related deaths occur in low- and lower-middle-income countries such as India and Bangladesh, where under-diagnosis and under-treatment is a challenge.
Increasing product approval from the U.S. FDA (Food and Drug Administration) by key market player is expected to boost the market growth over the forecast period. For instance, on April 4, 2022, GE Healthcare, a multinational company, announced the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. The company initially released the technology in Europe in 2010 and according to the latest announcement anesthesia providers use Et Control software to care for patients in over 100 countries. The Et Control software semi-automates the delivery of anesthesia using software, allowing anesthesia providers to set targets for end-tidal oxygen and anesthetic agent. Once targets are set, the software quickly achieves and maintains those targets, regardless of changes in the patient's hemodynamic and metabolic status. The Et Control software improves anesthesia delivery accuracy and simplifies workflows while reducing drug waste, lowering the cost of care and greenhouse gas emissions.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients